Skip to main content
Tech.euFundingExplorerBeta

Nanoligent

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

Barcelona, Spainwww.nanoligent.com ↗
Healthtech
← All companies
Total raised
€13M
€13,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2022-02
latest 2025-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood37
base rate 30% for Other
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)

    Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

    Funding rounds

    2 rounds
    DateStageAmountInvestors
    2025-10-10Other€12MBiotech IV fund,CDTI,Clave Capital,InvereadyView deal →
    2022-02-04Other€1.0MAVANTECA Partners,Italian Angels for Growth (IAG)View deal →

    Investors

    6
    AVANTECA PartnersBiotech IV fundCDTIClave CapitalInvereadyItalian Angels for Growth (IAG)

    Related news

    Similar companies

    same sector or country